WallStreetZenWallStreetZen

NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lawrence Otto KleinCEO2026-10-0116,246$83.40
$1.35MSell
Lawrence Otto KleinCEO2026-10-01200$84.78
$16.96kSell
Lawrence Otto KleinCEO2026-10-018,554$84.03
$718.76kSell
Lawrence Otto KleinCEO2026-10-0125,000$7.80
$195.00kBuy
Paul T. QuinlanCLO2026-09-212,900$92.37
$267.87kSell
Paul T. QuinlanCLO2026-09-212,667$95.31
$254.19kSell
Paul T. QuinlanCLO2026-09-21601$94.44
$56.76kSell
Paul T. QuinlanCLO2026-09-213,832$93.32
$357.59kSell
Paul T. QuinlanCLO2026-09-2110,000$7.80
$78.00kBuy
Arjun AgarwalSVP2026-09-21533$95.75
$51.03kSell

1 of 16

ORKA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Scott D. Sandell15.44%10,221,465$863.92MInsider
Krishna Kittu Kolluri15.44%10,221,465$863.92MInsider
Peter W. Sonsini15.44%10,221,465$863.92MInsider
Joshua Makower15.44%10,221,465$863.92MInsider
Anthony A. Florence Jr.15.44%10,221,465$863.92MInsider
Ravi Viswanathan15.44%10,221,465$863.92MInsider
Harry R. Weller15.44%10,221,465$863.92MInsider
David M. Mott15.44%10,221,465$863.92MInsider
Forest Baskett15.44%10,221,465$863.92MInsider
Peter J. Barris15.44%10,221,465$863.92MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA0.05%99.95%Net SellingNet Selling
SRRK0.11%67.31%Net Buying
MIRM0.11%81.26%Net BuyingNet Selling
COGT0.11%8.01%Net SellingNet Buying
TVTX0.11%61.52%Net SellingNet Selling
View Top Biotech Stocks

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 0.11% institutional shareholders, 232.46% Oruka Therapeutics insiders, and 0.00% retail investors. Scott D. Sandell is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 15.44% of the company. Scott D. Sandell's Oruka Therapeutics shares are currently valued at $863.92M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.